We are live on ! Find out more
SLNO

Soleno Therapeutics
SLNO

Delisted

SLNO was delisted on the 15th of May, 2026.

Back to rankings

66 hedge funds and large institutions have $110M invested in Soleno Therapeutics in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

334% more call options, than puts

Call options by funds: $395K | Put options by funds: $91K

136% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 11

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

15% more capital invested

Capital invested by funds: $96.1M → $110M (+$14.2M)

3% more funds holding

Funds holding: 64 → 66 (+2)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.16% less ownership

Funds ownership: 3.85% → 3.69% (-0.16%)

Holders
66
Holders Change
+2
Holders Change %
+3.13%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
26
Reduced
11
Closed
13
Calls
$395K
Puts
$91K
Net Calls
+$304K
Net Calls Change
-$1.39M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.24M
2
SCM
Suvretta Capital Management
New York
+$1.36M
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.34M
4
Two Sigma Investments
Two Sigma Investments
New York
+$1.06M
5
Goldman Sachs
Goldman Sachs
New York
+$583K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$2.74M
2
SB
Samsara BioCapital
California
-$1.67M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.36M
4
DCM
DAFNA Capital Management
California
-$827K
5
IC
Ikarian Capital
Texas
-$748K
Name Holding Trade Value Shares
Change 		Change in
Stake
A
1
Abingworth
United Kingdom
$25.8M – – –
NCM
2
Nantahala Capital Management
Connecticut
$18.6M – – –
OIM
3
Oracle Investment Management
Connecticut
$9.21M – – –
SCM
4
Suvretta Capital Management
New York
$8.1M +$1.36M +46,625 +28%
CCM
5
Consonance Capital Management
New York
$7.63M – – –
BlackRock
6
BlackRock
New York
$6.76M +$2.24M +76,676 +74%
GPCM
7
Granite Point Capital Management
Massachusetts
$5.52M – – –
CH
8
CVI Holdings
Delaware
$3.89M – – –
AIC
9
AWM Investment Company
New York
$3.89M – – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$3.77M +$230K +7,870 +9%
BC
11
Birchview Capital
Vermont
$2.08M – – –
Two Sigma Advisers
12
Two Sigma Advisers
New York
$1.76M +$1.34M +45,780 +5,014%
Northern Trust
13
Northern Trust
Illinois
$1.57M +$495K +16,941 +68%
Two Sigma Investments
14
Two Sigma Investments
New York
$1.49M +$1.06M +36,282 +1,125%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$1.42M +$388K +13,276 +54%
TMC
16
Trellus Management Company
Florida
$1.04M +$97.4K +3,333 +14%
State Street
17
State Street
Massachusetts
$967K +$168K +5,765 +29%
Goldman Sachs
18
Goldman Sachs
New York
$751K +$583K +19,950 New
JGC
19
J. Goldman & Co
New York
$607K -$303K -10,360 -39%
Squarepoint
20
Squarepoint
New York
$596K -$99.1K -3,390 -18%
Charles Schwab
21
Charles Schwab
California
$397K +$167K +5,725 +119%
BNP Paribas Financial Markets
22
BNP Paribas Financial Markets
France
$384K +$22.8K +780 +8%
GIM
23
Greylin Investment Management
Virginia
$337K +$261K +8,946 New
Nuveen
24
Nuveen
North Carolina
$319K +$52.6K +1,801 +27%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$305K +$85.4K +2,921 +56%
1
2 3 4

SLNO Hedge Fund Activity: Q3 2020 in Review

66 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Soleno Therapeutics (SLNO) for Q3 2020, worth a combined $110M — up 15% from $96.1M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new SLNO positions and 13 closed out — a net gain of 2 holders — while 26 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, adding an estimated $2.24M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $2.74M sold.

  • 66 institutional investors held Soleno Therapeutics (SLNO) as of Q3 2020, up from 64 in Q2 2020.
  • Funds reported $110M of Soleno Therapeutics stock for Q3 2020, up 15% quarter-over-quarter.
  • 15 funds opened new Soleno Therapeutics positions in Q3 2020 and 13 closed out, a net change of +2 holders.
  • The largest Soleno Therapeutics buyer in Q3 2020 was BlackRock, an estimated $2.24M added.
  • The largest Soleno Therapeutics seller in Q3 2020 was Sphera Funds Management, an estimated $2.74M sold.

Based on aggregated 13F filings for Q3 2020.